Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01283113 · ClinicalTrials.gov registry record
Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method
A clinical trial, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- 110
- Enrollment target
NCT01283113 is a clinical trial that has completed, run by Joslin Diabetes Center. The registered enrollment target is 110 participants.
The verdict
NCT01283113 has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The main aim of this study is to compare 2 different measurements of visceral fat that can be easily used in clinical practice (waist circumference versus bioelectric impedance) in relation to known risk factors of coronary artery disease in a large cohort of patients with type 2 diabetes and with a BMI range between 20-45 kg/m2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2010-08 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01283113
The ClinicalTrials.gov registry entry for NCT01283113 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01283113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01283113 about?
NCT01283113 is a clinical study titled "Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method". The main aim of this study is to compare 2 different measurements of visceral fat that can be easily used in clinical practice (waist circumference versus bioelectric impedance) in relation to known risk factors of coronary artery disease in a large cohort of patients with type 2 diabetes and with a...
What is the current status of trial NCT01283113?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2010-08. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT01283113?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.